For HCPs Only
Recent Clinical Updates
Loading latest clinical updates
All Authors
SP

HCP Connect Contributor

Dr. Shruti Pandey

Dr. Shruti Pandey contributes hematology drug update coverage for HCP Connect, with emphasis on source-verified therapeutic developments and practical clinical context for US-licensed practitioners. This profile links the author's recent clinical coverage, specialty focus, and professional contributor metadata in one place.

Recent Drug Updates

18 total

Hematology

NCCN Updates CAR-T Cell Therapy Guidelines: Improved Outcomes for DLBCL and Multiple Myeloma

NCCN updates CAR-T cell therapy guidelines for DLBCL and multiple myeloma, highlighting improved outcomes for patients.

May 7, 2026|3 min read|Via NCCN

Hematology

FDA Approves Fitusiran for Hemophilia: Reduced Bleeding Episodes with Subcutaneous Dosing

FDA approves fitusiran for hemophilia: reduced bleeding episodes with subcutaneous dosing every two months.

May 7, 2026|3 min read|Via FDA

Hematology

FDA Approves Imetelstat for MDS: 39.8% RBC Transfusion Independence

Imetelstat (Rytelo) approved for MDS: 39.8% RBC transfusion independence in low- to intermediate-1 risk patients.

May 6, 2026|3 min read|Via FDA

Hematology

FDA Approves Bitopertin for Erythropoietic Protoporphyria: A New Treatment Option

FDA approves bitopertin for erythropoietic protoporphyria: a new treatment option for managing protoporphyrin levels.

May 5, 2026|3 min read|Via FDA AccessData

Hematology

CAR-T Cell Therapy Shows Promising Outcomes for DLBCL and Multiple Myeloma in 2024

CAR-T cell therapy shows significant outcomes for DLBCL and multiple myeloma, with new data expected in 2024.

May 2, 2026|3 min read|Via WHO

Hematology

FDA Approves Narsoplimab for TA-TMA: First Treatment for Stem Cell Transplant Complication

FDA approves narsoplimab for TA-TMA: the first treatment for hematopoietic stem cell transplant complications.

May 2, 2026|3 min read|Via FDA

Hematology

FDA Approves Fitusiran for Hemophilia: Antithrombin Lowering Therapy for Patients 12 and Older

FDA approves fitusiran for hemophilia: Antithrombin lowering therapy for patients 12 and older, enhancing treatment adherence.

May 1, 2026|3 min read|Via FDA

Medical Research

Novel Therapy Achieves 90% Response in Rare Sarcoma

New targeted radiation approach reduces cancer activity and provides symptom relief in patients with solitary fibrous tumors, a rare and often malignant soft tissue tumor.

Apr 24, 2026|2 min read|Via Medical Xpress

Medical Research

Cut Opioid Relapse Rates with Evidence-Based Meds

Learn how primary care clinics can help curb the opioid epidemic with effective medications and overcome treatment barriers to improve patient outcomes.

Apr 20, 2026|2 min read|Via Medical Xpress

Healthcare Business

Integrated Care Cuts Pediatric Behavioral Issues by 30%

Discover how integrated primary care services can improve pediatric behavioral health outcomes and reduce symptom scores in children, enhancing overall well-being and quality of li...

Apr 18, 2026|5 min read|Via American Journal Managed Care

Medical Research

Identify Microcephaly Cause with SNW1 Gene Mutation

Discover how mutations in the SNW1 gene are linked to neurodevelopment disorders with microcephaly, informing diagnosis and treatment approaches for affected patients.

Apr 13, 2026|64 min read|Via Journal of Clinical Investigation

Medical Research

Uncover Root Causes of Liver Fibrosis

Discover how metabolic dysfunction and lipid accumulation contribute to liver fibrosis, and learn how to identify and manage underlying causes in your patients.

Apr 13, 2026|17 min read|Via Journal of Clinical Investigation

Medical Research

Uncover Microbiome's Role in RA Progression

Discover how microbiome changes impact rheumatoid arthritis treatment and patient outcomes, and what it means for your practice.

Apr 12, 2026|25 min read|Via Journal of Clinical Investigation

Medical Research

Reduces EPP-Related Liver Disease by Targeting Erythroid PPIX

Discover how inhibiting GLYT1 mitigates liver disease in erythroid protoporphyria, reducing phototoxicity and improving patient outcomes.

Apr 11, 2026|31 min read|Via Journal of Clinical Investigation

Medical Research

New Opioid 20x Stronger Than Fentanyl Fuels Overdose Crisis

A highly potent synthetic opioid is driving the overdose crisis, with potency hundreds of times stronger than morphine, posing a new threat to patient safety.

Apr 7, 2026|3 min read|Via Medical Xpress

Pharmaceutical

Novel Protein Degraders May Revolutionize Immune Condition Treatment

Discover how new protein degrader drugs can improve treatment outcomes for immune conditions, with potential for enhanced efficacy and reduced side effects.

Mar 28, 2026|2 min read|Via BioPharma Dive

Digital Health

Boost Trial Efficiency with Data-Driven Site Selection

Discover how AI-powered site selection can streamline clinical trials, saving time and resources for sponsors and improving trial accessibility.

Mar 28, 2026|3 min read|Via HIT Consultant

Health IT

Identify K 18 Small White Pill for Patient Safety

Quickly identify the K 18 small white pill to ensure patient safety and accurate medication administration in your practice.

Mar 24, 2026|12 min read|Via HIStalk